Myocardial Protection Effect of Simvastatin Undergoing Cardiac Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSun Yat-sen University

About this trial

Statins have been used to low cholesterol to prevent and treat coronary artery diseases. It was also reported that statins could protect endothelial function and cardiac function during coronary artery bypass graft. The investigators recent found simvastatin reduced myocardial injury during noncoronary artery cardiac surgery in single medical center. The investigators further investigate that whether simvastatin can protect myocardium during noncoronary artery cardiac surgery with cardiopulmonary bypass and improve cardiac function with long term use postoperatively in two medical centers.

Eligibility criteria

Qualifiers

More than 18-year-old,

Congenital heart disease(not complex),

Isolated heart valve disease,

Disqualifiers

Coronary artery disease

Allergy for statins

Poor liver function,Hepatitis

Gestation women and Breast-feeding women

Trial design

Treatments tested in this trial

  • simvastatin

Treatment groups

369 Participants
are divided into 3 treatment groups

Sponsors and collaborators